Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Depreciation & Amortization (CF) (2018 - 2025)

Dna X (SONM) has disclosed Depreciation & Amortization (CF) for 8 consecutive years, with $952000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation & Amortization (CF) rose 3.7% year-over-year to $952000.0, compared with a TTM value of $3.7 million through Sep 2025, up 3.31%, and an annual FY2024 reading of $3.6 million, up 61.24% over the prior year.
  • Depreciation & Amortization (CF) was $952000.0 for Q3 2025 at Dna X, up from $797000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $1.8 million in Q4 2022 and bottomed at $67000.0 in Q3 2023.
  • Average Depreciation & Amortization (CF) over 5 years is $687947.4, with a median of $630000.0 recorded in 2023.
  • The sharpest move saw Depreciation & Amortization (CF) tumbled 71.84% in 2022, then skyrocketed 1270.15% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $498000.0 in 2021, then skyrocketed by 265.46% to $1.8 million in 2022, then plummeted by 47.47% to $956000.0 in 2023, then dropped by 4.39% to $914000.0 in 2024, then increased by 4.16% to $952000.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for SONM at $952000.0 in Q3 2025, $797000.0 in Q2 2025, and $1.1 million in Q1 2025.